亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

CELL-MATRIX MICROSPHERES, METHODS FOR PREPARATION AND APPLICATIONS

總結
A method has been developed to produce stable cell-matrix microspheres with up to 100% encapsulation efficiency and high cell viability, using matrix or biomaterial systems with poor shape and mechanical stability for applications including cell therapeutics via microinjection or surgical implantation, 3D culture for in vitro expansion without repeated cell splitting using enzymatic digestion or mechanical dissociation and for enhanced production of therapeutic biomolecules, and in vitro modelling for morphogenesis studies. The modified droplet generation method is simple and scalable and enables the production of cell-matrix microspheres when the matrix or biomaterial system used has low concentration, with slow phase transition, with poor shape and mechanical stability.
附加資料
Patent Number: US8679809B2
Application Number: US2007750863A
Inventor: Chan, Barbara Pui | Chan, Godfrey Chi-Fung | Wong, Hoi Ling | Cheung, Pik To | Cheah, Song-Eng Kathryn | Chan, Danny
Priority Date: 19 May 2006
Priority Number: US8679809B2
Application Date: 18 May 2007
Publication Date: 25 Mar 2014
IPC Current: C12N001104 | C12N0005077 | C12N00050775
US Class: 435177 | 4240937
Assignee Applicant: The University of Hong Kong
Title: Cell-matrix microspheres, methods for preparation and applications
Usefulness: Cell-matrix microspheres, methods for preparation and applications
Summary: The cell-matrix microsphere can be used for producing a biomolecule and for injecting or implanting into tissues of animals or humans (claimed), for tissue repair or regeneration, e.g. for skin wound or an injured cartilage. It can also be used as therapeutics, and as three-dimensional (3D) microcarriers. The cell-matrix microspheres can also be used to immobilize other therapeutic molecules, e.g. factors inducing specific differentiation lineage such as Transforming Growth Factor (TGF) beta for chondrogenic differentiation, and anti-inflammatory drugs.
Novelty: New cell-matrix microspheres comprises an extracellular matrix forming a nanofibrous microsphere, useful for producing a biomolecule and for injecting or implanting into tissues of animals or humans for tissue repair or regeneration
主要類別
診斷/治療
細分類別
其他疾病
申請號碼
CN200780018296A
國家/地區
香港

欲了解更多信息,請點擊 這裡
移動設備